Metropolitan Life Insurance Company (MetLife)’s MaxLinear MXL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,323	Closed	-$80.7K	–	1342
2024 Q1	$80.7K	Sell	4,323 -158	-4%	-$3.15K	﹤0.01%	1168
2023 Q4	$107K	Hold	4,481	–	–	0.01%	1045
2023 Q3	$99.7K	Buy	4,481 +444	+11%	+$11.3K	0.01%	1012
2023 Q2	$127K	Hold	4,037	–	–	0.01%	893
2023 Q1	$142K	Sell	4,037 -396	-9%	-$14.3K	0.01%	819
2022 Q4	$151K	Hold	4,433	–	–	0.01%	843
2022 Q3	$145K	Hold	4,433	–	–	0.01%	815
2022 Q2	$151K	Hold	4,433	–	–	0.01%	844
2022 Q1	$259K	Sell	4,433 -13,567	-75%	-$826K	0.01%	703
2021 Q4	$1.36M	Sell	18,000 -601	-3%	-$38.5K	0.02%	750
2021 Q3	$916K	Hold	18,601	–	–	0.01%	1026
2021 Q2	$790K	Sell	18,601 -407	-2%	-$15.2K	0.01%	1185
2021 Q1	$648K	Sell	19,008 -897	-5%	-$32K	0.01%	1256
2020 Q4	$760K	Hold	19,905	–	–	0.01%	1080
2020 Q3	$463K	Hold	19,905	–	–	0.01%	1272
2020 Q2	$427K	Hold	19,905	–	–	0.01%	1331
2020 Q1	$232K	Hold	19,905	–	–	﹤0.01%	1509
2019 Q4	$422K	Sell	19,905 -741	-4%	-$15.4K	0.01%	1437
2019 Q3	$462K	Hold	20,646	–	–	0.01%	1347
2019 Q2	$484K	Buy	20,646 +647	+3%	+$15.8K	0.01%	1328
2019 Q1	$511K	Hold	19,999	–	–	0.01%	1282
2018 Q4	$352K	Hold	19,999	–	–	0.01%	1440
2018 Q3	$398K	Hold	19,999	–	–	0.01%	1527
2018 Q2	$312K	Hold	19,999	–	–	0.01%	1632
2018 Q1	$455K	Buy	19,999 +451	+2%	+$11.2K	0.01%	1342
2017 Q4	$516K	Sell	19,548 -19,744	-50%	-$493K	0.01%	1268
2017 Q3	$933K	Hold	39,292	–	–	0.01%	1295
2017 Q2	$1.1M	Buy	39,292 +426	+1%	+$12.4K	0.01%	1189
2017 Q1	$1.09M	Hold	38,866	–	–	0.01%	1186
2016 Q4	$847K	Hold	38,866	–	–	0.01%	1387
2016 Q3	$788K	Hold	38,866	–	–	0.01%	1422
2016 Q2	$699K	Hold	38,866	–	–	0.01%	1479
2016 Q1	$719K	Buy	38,866 +3,503	+10%	+$55.6K	0.01%	1355
2015 Q4	$521K	Buy	35,363 +3,485	+11%	+$52.4K	﹤0.01%	1599
2015 Q3	$397K	Sell	31,878 -2,943	-8%	-$32.4K	﹤0.01%	1787
2015 Q2	$421K	Buy	34,821 +14,460	+71%	+$145K	﹤0.01%	1864
2015 Q1	$166K	Hold	20,361	–	–	﹤0.01%	2135
2014 Q4	$151K	Hold	20,361	–	–	﹤0.01%	2551
2014 Q3	$140K	Hold	20,361	–	–	﹤0.01%	2566
2014 Q2	$205K	Buy	20,361 +37	+0.2%	+$339	﹤0.01%	2494
2014 Q1	$193K	Hold	20,324	–	–	﹤0.01%	2481
2013 Q4	$212K	Hold	20,324	–	–	﹤0.01%	2427
2013 Q3	$168K	Sell	20,324 -425	-2%	-$3.31K	﹤0.01%	2542
2013 Q2	$145K	Buy	+20,749	New	+$131K	﹤0.01%	2571

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MXL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of MaxLinear (MXL) in Q2 2024, closing a stake of 4,323 shares — an estimated $80.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MXL in Q2 2013 and held it in 44 quarters. The position peaked at $1.36M in Q4 2021. 214 funds tracked by Wall St. Rank hold MXL as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining MaxLinear position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 4,323 MaxLinear shares in Q2 2024, an estimated $80.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in MaxLinear in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s MaxLinear position peaked at $1.36M in Q4 2021.
214 funds tracked by Wall St. Rank held MaxLinear as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.